MISSION Therapeutics' Series B Round

MISSION Therapeutics raised a round of funding on November 18, 2013.

MISSION Therapeutics is a private drug discovery company focused on elucidating and targeting the ubiquitin pathway to treat cancers and other diseases. The company is developing small molecule drugs …

Articles about MISSION Therapeutics' Series B Round: